VISEN Pharmaceuticals (HKG:2561)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
19.04
-0.06 (-0.31%)
Sep 18, 2026, 4:08 PM HKT

VISEN Pharmaceuticals Statistics

Total Valuation

HKG:2561 has a market cap or net worth of HKD 2.08 billion. The enterprise value is 1.70 billion.

Market Cap2.08B
Enterprise Value 1.70B

Important Dates

The last earnings date was Thursday, August 27, 2026.

Earnings Date Aug 27, 2026
Ex-Dividend Date n/a

Share Statistics

HKG:2561 has 109.30 million shares outstanding. The number of shares has increased by 12.01% in one year.

Current Share Class 109.30M
Shares Outstanding 109.30M
Shares Change (YoY) +12.01%
Shares Change (QoQ) +7.23%
Owned by Insiders (%) 4.87%
Owned by Institutions (%) 0.06%
Float 25.67M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 52.92
PB Ratio 2.69
P/TBV Ratio 2.69
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 43.26
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.00, with a Debt / Equity ratio of 0.26.

Current Ratio 4.00
Quick Ratio 2.55
Debt / Equity 0.26
Debt / EBITDA n/a
Debt / FCF -0.38
Interest Coverage -71.97

Financial Efficiency

Return on equity (ROE) is -31.37% and return on invested capital (ROIC) is -16.31%.

Return on Equity (ROE) -31.37%
Return on Assets (ROA) -15.62%
Return on Invested Capital (ROIC) -16.31%
Return on Capital Employed (ROCE) -32.96%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee 385,515
Profits Per Employee -2.71M
Employee Count82
Asset Turnover 0.04
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -57.69% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -57.69%
50-Day Moving Average 19.63
200-Day Moving Average 26.47
Relative Strength Index (RSI) 42.05
Average Volume (20 Days) 13,090

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, HKG:2561 had revenue of HKD 39.32 million and -276.50 million in losses. Loss per share was -2.55.

Revenue39.32M
Gross Profit 20.13M
Operating Income -256.82M
Pretax Income -276.50M
Net Income -276.50M
EBITDA -256.11M
EBIT -256.82M
Loss Per Share -2.55
Full Income Statement

Balance Sheet

The company has 583.94 million in cash and 204.00 million in debt, with a net cash position of 379.93 million or 3.48 per share.

Cash & Cash Equivalents 583.94M
Total Debt 204.00M
Net Cash 379.93M
Net Cash Per Share 3.48
Equity (Book Value) 774.93M
Book Value Per Share 7.09
Working Capital 735.71M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -528.86 million and capital expenditures -2.13 million, giving a free cash flow of -530.99 million.

Operating Cash Flow -528.86M
Capital Expenditures -2.13M
Depreciation & Amortization 720,158
Net Borrowing 196.14M
Free Cash Flow -530.99M
FCF Per Share -4.86
Full Cash Flow Statement

Margins

Gross Margin 51.19%
Operating Margin -653.11%
Pretax Margin -703.16%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

HKG:2561 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -12.01%
Shareholder Yield -12.01%
Earnings Yield -13.29%
FCF Yield -25.52%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

HKG:2561 has an Altman Z-Score of 6.18.

Altman Z-Score 6.18
Piotroski F-Score n/a